ArticleFrontiers in pharmacology2020

(-)-Sativan Inhibits Tumor Development and Regulates miR-200c/PD-L1 in Triple Negative Breast Cancer Cells.

Fu Peng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.